CIBC Bancorp USA’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
CIBC Bancorp USA's RXRX Position: Q3 2026 in Review
CIBC Bancorp USA increased its Recursion Pharmaceuticals (RXRX) stake by 79% in Q3 2026, buying an estimated $75.7K and bringing the position to 50,744 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1961.
CIBC Bancorp USA first reported a position in RXRX in Q3 2025 and has held it in 4 quarters since. 350 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- CIBC Bancorp USA held 50,744 shares of Recursion Pharmaceuticals worth $210K as of Q3 2026.
- CIBC Bancorp USA bought 22,339 Recursion Pharmaceuticals shares in Q3 2026, an estimated $75.7K.
- Recursion Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1961 holding.
- CIBC Bancorp USA first reported a position in Recursion Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 350 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.